NCT01062659 arm group a505208877241efa57b9fbf6ba1c906f [clinicaltrials_resource:NCT01062659/arm-group/a505208877241efa57b9fbf6ba1c906f]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01062659 arm group a505208877241efa57b9fbf6ba1c906f [clinicaltrials_resource:NCT01062659/arm-group/a505208877241efa57b9fbf6ba1c906f]
Bio2RDF identifier
NCT01062659/arm-group/a505208877241efa57b9fbf6ba1c906f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 05208877241efa57b9fbf6ba1c906f
description [clinicaltrials_vocabulary:description]
Patients with chronic Hepatitis C (CHC) Genotype 1-4 who are naive to antiviral treatment
identifier
clinicaltrials_resource:NCT01062659/arm-group/a505208877241efa57b9fbf6ba1c906f
title
NCT01062659 arm group a505208877241efa57b9fbf6ba1c906f
@en
type
label
NCT01062659 arm group a5052088 ...... 5208877241efa57b9fbf6ba1c906f]
@en